Dapsone Patent Expiration
Dapsone is used for treating acne vulgaris through topical application. It was first introduced by Abbvie Inc
Dapsone Patents
Given below is the list of patents protecting Dapsone, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Aczone | US11273132 | Topical dapsone and dapsone/adapalene compositions and methods for use thereof | Nov 18, 2033 | Almirall |
| Aczone | US9161926 | Topical dapsone and dapsone/adaplene compositions and methods for use thereof | Nov 18, 2033 | Almirall |
| Aczone | US9517219 | Topical dapsone and dapsone/adapalene compositions and methods for use thereof | Nov 18, 2033 | Almirall |
| Aczone | US5863560 | Compositions and methods for topical application of therapeutic agents |
Sep 11, 2016
(Expired) | Abbvie |
| Aczone | US5863560 | Compositions and methods for topical application of therapeutic agents |
Sep 11, 2016
(Expired) | Almirall |
| Aczone | US6060085 | Compositions and methods for topical application of therapeutic agents |
Sep 11, 2016
(Expired) | Abbvie |
| Aczone | US6060085 | Compositions and methods for topical application of therapeutic agents |
Sep 11, 2016
(Expired) | Almirall |
| Aczone | US6620435 | Compositions for topical application of therapeutic agents |
Sep 11, 2016
(Expired) | Abbvie |
| Aczone | US6620435 | Compositions for topical application of therapeutic agents |
Sep 11, 2016
(Expired) | Almirall |
Dapsone's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List